ABSTRACT. A West Highland White Terrier was brought to our veterinary hospital with the chief complaints of seizures and staggering gait. When cephalic Magnetic resonance imaging (MRI) was performed, a symmetrical lesion was found in the basal ganglion. Suspecting a metabolic disorder, an abdominal ultrasonography was performed, and a tumor was found in the pancreas. The pancreatic tumor was surgically removed based on suspicion that it had induced the brain damage. The resected tumor was histopathologically diagnosed as an insulinoma. After removal, recurrence of neurological symptoms was not observed. MRI 3 months post-operation showed a reduction in the size of the brain lesion. Consequently, the tumor was thought to have induced the lesion in the basal ganglion, and this was verified by MRI. This case was considered to be extremely rare. KEY WORDS: canine, insulinoma, magnetic resonance imaging (MRI).
In the field of veterinary medicine, numerous cases are encountered where the chief complaint for visiting the veterinary clinic is cerebral or neurological symptoms caused by various factors such as congenital disease, viral infectious disease, brain cancer, cerebral hemorrhage, and cerebral edema. On the other hand, among cases presenting cerebral and nervous symptoms in the field of medicine, systemic metabolic disorders promoting the development of secondary cerebral parenchymal abnormalities and causing neurological symptoms have been reported. However, although there have been reports in which MRI has confirmed cerebral parenchymal abnormalities caused by such systemic metabolic disorders in veterinary medicine, in actuality, their occurrence is very rare. In the present case, we examined a dog that was brought to our veterinary hospital with cerebral and neurological symptoms as the chief complaints. Magnetic resonance imaging (MRI) showed symmetrical lesions in the basal ganglion, and abdominal ultrasonography demonstrated a tumor in the pancreas. Consequently, we surgically removed the suspected pancreatic tumor responsible for the pancreatic tumor-induced brain damage. The histopathology of the excised tumor demonstrated insulinoma. We herein report an extremely rare case of insulinoma in a dog.
A 6-year-old, female West Highland White Terrier was brought to a local clinic with the chief complaints of gait abnormalities, tachypnea and salivation. On the first examination at the clinic, seizure with a swimming motion was observed. Blood examination revealed a slight decrease in the blood glucose level (56 mg/dl). With no abnormal findings on other tests, prednisolone and antibiotics were given to treat the neurological symptoms. However, the symptoms were repeatedly observed thereafter. Seizure was observed when the dose of prednisolone was reduced. The blood glucose level at the onset of seizure hovered around 55 mg/dl, excluding hypoglycemic seizure. The dog was thus suspected to have an intracranial lesion and was brought to our veterinary hospital.
When the dog arrived at our hospital, no abnormal clinical symptoms were observed. Neither an overall examination nor neurological tests showed any abnormalities. A blood test showed elevated levels of hepatic enzymes and an increased WBC count, which were attributed to administration of steroids. The blood glucose level (106 mg/dl) was within the normal range. No particular abnormalities were seen on thoracic radiographs, although the liver appeared large on abdominal radiographs, but this was thought to be due to the administration of steroids. Consequently, an intracranial lesion was suspected, and a cephalic MRI was performed. Cephalic MRI was performed using T1-weighted imaging (TR 500, TE 15), T2-weighted imaging (TR 4000, TE 100), FLAIR imaging (TR 8000, TE 120). Contrast-enhanced T1-weighted images were acquired by gadoteridol enhancement (ProHance, 0.2 mol/kg). T2-weighted and FLAIR images showed a symmetrically scattered high signal intensity in the basal ganglion ( Fig. 1-A,  B ). In the T1-weighted images, the same area showed a high signal intensity peripherally and a low signal intensity centrally ( Fig. 1-C) . No increase in signal intensity was observed in the same area during the contrast study ( Fig. 1-D) . After MRI was performed, a cerebral spinal fluid test showed a 0/l cell count. Low lymphocyte and macrophage counts were verified during a centrifuge smear test, without any abnormalities. Cephalic MRI showed no abnormalities other than a bilaterally symmetrical lesion in the basal ganglion, and the findings from the other tests led us to suspect poisoning or a metabolic disorder. Discussions with the owner and the fact that the dog was a house pet led us to believe that the possibility of poisoning was low. Consequently, we suspected a metabolic disorder, and thus carried out abdominal ultrasonography, which showed a low-echo mass 8 mm in diameter in the pancreatic body. We subsequently surgically removed the tumor. During laparotomy, we were unable to verify the left pancreatic lobe and were only able to confirm the pancreatic body and right pancreatic lobe. As noted in the ultrasonography findings, the tumor was in the pancreatic body. The shape of the pancreas was abnormal, and because the tumor developed within the pancreas, we were able to surgically remove it without causing damage to the pancreatic ducts. Histopathological examination of the resected tissue revealed an insulinoma. Because we removed only the tumor, carboplatin was prescribed following surgery. Immediately after surgery, the dog's neurological symptoms improved, the seizures completely disappeared and the blood glucose level shifted to around 100 mg/dl. On the 8th day after surgery, the insulin level was within the normal range at 14.92 U/ml.
No seizures have been observed in the 3 months since the surgery. During cephalic MRI for detailed examination of the basal ganglion lesion, the high intensity signal observed in the periphery of the basal ganglion during T1-weighted imaging of the lesion was no longer visible, and only a low intensity signal was observed in the central part (Fig. 2-C) . During T2-weighted and FLAIR imaging, the high intensity signal in the periphery disappeared, and high intensity signals were only observed in the area with low intensity signal during T1-weighted imaging (Fig. 2-A, B) .
Because T1 values are increased in many intracranial pathologies, the tendency for occurrence of low signal intensity during T1-weighted imaging is limited to patho- logic conditions with high signal intensities [9, 10] . In the medical field, changes in the bilateral basal ganglion as observed by MRI are related to pathologic conditions with high signal intensities on T1-weighted imaging, such as hepatic encephalopathy, hypoxic encephalosis, hypoglycemia, neurofibromatosis type 1, central venous nutrition and diabetes [4, 10] . On the other hand, there are reports indicating changes in signal intensity in the basal ganglion and hippocampus in cases of insulinoma [2] . Even among these pathologic conditions, differences in signal intensity can be observed in T2-weighted imaging. The signal intensities in T2-weighted imaging of diabetes and hepatic encephalopathy have been reported to be low to moderate [4, 10] . Conversely, hypoglycemia and insulinoma exhibit high signal intensities [2, 6, 7, 10] . The mechanism producing this signal shift in hepatic encephalopathy and diabetes is believed to be due to deposition of paramagnetic substances, such as manganese, and an increase in the thickness of the intracellular membrane structure, enhancement of petechial hemorrhaging and ischemia [4, 10] . The mechanism producing the signal shift in hypoglycemia and insulinoma is thought to be caused by cellular edema, but there are no conclusive findings thus far [6, 7] . In the field of veterinary medicine, abnormalities in the basal ganglion are caused by portosystemic shunt in dogs, and there are reports indicating the potential to detect such abnormalities using MRI [8] , there are also reports showing that cerebral cortex abnormalities have been detected using MRI in dogs with hypoadrenal crisis [1] . Moreover, in dogs with insulinomas, pathological abnormalities in the cerebral cortex, dentate gyrus and hippocampus have been reported [5] . However, to the best of our knowledge, detection of such abnormalities using MRI has not been reported to date. In the present case, because initial T1-weighted imaging showed high signal intensity in Fig. 2 . Postoperative transverse MRI of the brain. High signal intensity was not observed in the lesion, and only low signal intensity was observed in the internal region of the lesion on T1-weighed image (C; arrows). The low-signal intensity region on T1-weighted image had high signal intensity on T2-weighted and FLAIR images (A and B; arrows).
the peripheral basal ganglion region and low signal intensity in the central region and MRI 3 months post-operation showed that there was a decrease in the signal intensity in the peripheral region, the changes in that location were assessed as reversible. Conversely, because the low-signal intensity region observed in the lesion on T1-weighted imaging during the initial MRI remained subsequent to surgery, that location was assessed as non-reversible, and we believe that some organic changes were present within the cells. Moreover, MRI subsequent to surgery revealed a reduction in the size of the lesion that was similar to reports in the medical community [6] , and the hypoglycemic condition that was producing the insulinoma was found to be responsible for the lesion in the basal ganglion.
In this single case of canine insulinoma, a symmetrical lesion was detected in the basal ganglion using MRI, and similar to cases of human insulinoma [6] , we found that brain damage can also occur in canine insulinoma.
In addition, among all cases of insulinoma, there are cases in which a subject presenting insulinoma has a blood glucose level within the normal range [3] , and in cases where steroids are prescribed, there are situations when differentiation of seizures is difficult. In this case, obtaining cephalic MRI findings suggesting a metabolic disorder is thought to be extremely useful for diagnosis, however, because we have not been able to find any reports of other animal cases, we hope to continue accumulating information on additional cases and to monitor the progress of this case.
